{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-141816","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2024-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.800047+00:00","generated_at":"2026-06-01T16:18:47.633957+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Finch Therapeutics receives additional delisting notice, requests transfer to Nasdaq Capital Market","bullets":["Nasdaq issued Additional Staff Determination on May 14, 2024, for continued noncompliance with $5M MVPHS Rule.","Company failed to regain compliance by May 13, 2024 deadline; first flagged Nov 15, 2023.","Company also deemed a 'public shell'; appeal hearing held April 23, 2024, decision pending.","On May 15, 2024, Company requested transfer from Nasdaq Global Select to Nasdaq Capital Market; no guarantee of approval."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-141816","json":"https://secwatch.observer/filing/0001193125-24-141816.json","markdown":"https://secwatch.observer/filing/0001193125-24-141816.md","text":"https://secwatch.observer/filing/0001193125-24-141816.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/0001193125-24-141816-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/d800582d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T16:18:47.633957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c71f13ae88d7b7d3210428d175801ca5585059fc","claim":"Finch Therapeutics Group, Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(1)(C)).","evidence_excerpt":"May 14, 2024, the Nasdaq Listing Qualifications Department issued an Additional Staff Determination that the Company’s continued noncompliance with the MVPHS Rule serves as an additional basis for delisting the Common Stock from The Nasdaq Global Select Market. Also as previously disclosed, the Company previously received a determination letter from the Nasdaq Listing Qualifications Department informing the Company of Nasdaq’s belief that the Company is a “public shell” under the Nasdaq criteria. The Company appealed the Nasdaq Listing Qualifications Department’s determination with respect to","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1733257/000119312524141816/0001193125-24-141816-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5450(b)(1)(C)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}